Fulcrum Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.81M Buy
23,792
+1,066
+5% +$123K 0.42% 63
2025
Q4
$2.41M Sell
22,726
-673
-3% -$63.2K 0.67% 40
2025
Q3
$1.96M Sell
23,399
-650
-3% -$53.5K 0.54% 50
2025
Q2
$1.9M Buy
+24,049
New +$1.91M 0.54% 49
2022
Q1
Hold
0
70
2021
Q4
Hold
0
27
2021
Q3
Hold
0
27
2021
Q2
Hold
0
32
2021
Q1
Hold
0
21

Other funds holding MRK

Fulcrum Asset Management's MRK Position: Q1 2026 in Review

Fulcrum Asset Management increased its Merck (MRK) stake by 4.7% in Q1 2026, buying an estimated $123K and bringing the position to 23,792 shares worth $2.81M. The position accounts for 0.42% of the portfolio, ranked #63.

Fulcrum Asset Management first reported a position in MRK in Q2 2025 and has held it in 4 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Fulcrum Asset Management held 23,792 shares of Merck worth $2.81M as of Q1 2026.
  • Fulcrum Asset Management bought 1,066 Merck shares in Q1 2026, an estimated $123K.
  • Merck made up 0.42% of Fulcrum Asset Management's portfolio in Q1 2026, its #63 holding.
  • Fulcrum Asset Management first reported a position in Merck in Q2 2025 and has held it in 4 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Fulcrum Asset Management's 13F filing for Q1 2026, filed 14 May 2026.